The Journal of Immunology, Vol 146, Issue 2 708-714, Copyright © 1991 by American Association of Immunologists

ARTICLES

Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators

IM Katona, K Ohura, JB Allen, LM Wahl, DE Chenoweth and SM Wahl
Department of Pediatrics and Medicine, Uniformed Services University of the Health Sciences, F. Edward Hebert School of Medicine, Bethesda, MD 20814-4799.

Monocyte recruitment and accumulation in the synovial tissue is pivotal in the evolution of rheumatoid arthritis (RA). In the present study we examined the chemotactic potential of monocytes obtained from synovial fluid (SF) of patients with RA. Functionally, SF monocytes exhibited greatly diminished chemotactic activity to C5a compared with monocytes from the peripheral blood. In contrast, their chemotactic responsiveness to the synthetic peptide, FMLP, was nearly normal. To define a mechanism for this differential chemotactic dysfunction, cell- surface receptors for C5a (C5aR) and FMLP (FMLP-R) were evaluated. Whereas FMLP-R expression was similar on both blood and inflammatory monocytes, C5aR expression was markedly reduced on SF cells. Because decreased C5a binding in certain RA SF samples could not be attributed to free C5a, known or suspected components of inflammatory SF were evaluated for their ability to modulate chemotactic ligand receptors. Bacterial products including LPS and streptococcal cell walls, which are potent monocyte activators, down-regulated C5aR without affecting FMLP-R. Moreover, the cytokines IFN-gamma and granulocyte-macrophage- CSF selectively decreased C5aR in parallel with decreased in vitro chemotactic activity to C5a. Thus, these data indicate that 1) synovial effusions may contain C5a and/or inflammatory mediators that modulate phenotypic and functional changes in monocytes, 2) chemotactic ligand receptors are independently regulated in inflammatory lesions, and 3) decreased C5aR expression and chemotactic potential likely provide a mechanism whereby monocyte-macrophages persist within the inflamed synovium.

This article has been cited by other articles:

				I. Colmegna, R. Cuchacovich, and L. R. Espinoza HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations Clin. Microbiol. Rev., April 1, 2004; 17(2): 348 - 369. [Abstract] [Full Text] [PDF]

				Y. Cui, Y. Le, H. Yazawa, W. Gong, and J. M. Wang Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease J. Leukoc. Biol., October 1, 2002; 72(4): 628 - 635. [Abstract] [Full Text] [PDF]

				Y.-H. Cui, Y. Le, W. Gong, P. Proost, J. Van Damme, W. J. Murphy, and J. M. Wang Bacterial Lipopolysaccharide Selectively Up-Regulates the Function of the Chemotactic Peptide Receptor Formyl Peptide Receptor 2 in Murine Microglial Cells J. Immunol., January 1, 2002; 168(1): 434 - 442. [Abstract] [Full Text] [PDF]

				K. E. Kempsell, C. J. Cox, A. A. McColm, J. A. Bagshaw, R. Reece, D. J. Veale, P. Emery, J. D. Isaacs, J. S. H. Gaston, and J. S. Crowe Detection of Mycobacterium tuberculosis Group Organisms in Human and Mouse Joint Tissue by Reverse Transcriptase PCR: Prevalence in Diseased Synovial Tissue Suggests Lack of Specific Association with Rheumatoid Arthritis Infect. Immun., March 1, 2001; 69(3): 1821 - 1831. [Abstract] [Full Text] [PDF]

				B. Denecke, A. Meyerdierks, and E. C. Bottger RGS1 Is Expressed in Monocytes and Acts as a GTPase-activating Protein for G-protein-coupled Chemoattractant Receptors J. Biol. Chem., September 17, 1999; 274(38): 26860 - 26868. [Abstract] [Full Text] [PDF]

				D. Cox, P. Chang, Q. Zhang, P. G. Reddy, G. M. Bokoch, and S. Greenberg Requirements for Both Rac1 and Cdc42 in Membrane Ruffling and Phagocytosis in Leukocytes J. Exp. Med., November 3, 1997; 186(9): 1487 - 1494. [Abstract] [Full Text] [PDF]